Use of Tegwondo, a near-continuous temozolomide regimen, in high- and low-grade gliomas.

被引：1
|
作者：
Strik, H. M.
Bock, H. C.
Marosi, C.
机构：
[1] Univ Marburg, Marburg, Germany
[2] Univ Gottingen, D-37073 Gottingen, Germany
[3] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[4] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2084
引用
收藏
页数：1
相关论文
共 50 条
  • [41] INTRA-TUMOR HETEROGENEITY ANALYSIS OF LOW-GRADE GLIOMAS. A POLA NETWORK STUDY
    Alentorn, A.
    Labreche, K.
    Dehais, C.
    Carpentier, C.
    Ducray, F.
    Mokhtari, K.
    Figarella-Branger, D.
    Sanson, M.
    Delattre, J.
    Idbaih, A.
    NEURO-ONCOLOGY, 2018, 20 : 266 - 266
  • [42] Severe thrombocytopenia from temozolomide (TMZ) in newly diagnosed patients with high-grade gliomas.
    Gerber, David E.
    Grossman, Stuart A.
    CANCER RESEARCH, 2006, 66 (08)
  • [43] MR perfusion of low-grade and high-grade gliomas
    Schockee, M.
    Stockhammer, G.
    Kolbitsch, C.
    Kremser, C.
    Obwegeser, A.
    Maier, H.
    Felber, S.
    Acta Radiologica Supplementum, 2000, 41 (Suppl 422)
  • [44] Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model
    Ollier, Edouard
    Mazzocco, Pauline
    Ricard, Damien
    Kaloshi, Gentian
    Idbaih, Ahmed
    Alentorn, Agusti
    Psimaras, Dimitri
    Honnorat, Jerome
    Delattre, Jean-Yves
    Grenier, Emmanuel
    Ducray, Francois
    Samson, Adeline
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (03) : 347 - 358
  • [45] Phase II study of prolonged daily temozolomide for low-grade gliomas in adults
    Kesari, Santosh
    Schiff, David
    Drappatz, Jan
    Gigas, Debra
    Doherty, Lisa
    Ligon, Keith
    Muzikansky, Alona
    Ciampa, Abgail
    Bradshaw, Joanna
    Levy, Brenda
    Radakovic, Gospova
    Ramakrishna, Naren
    Black, Peter
    Wen, Patrick
    NEURO-ONCOLOGY, 2007, 9 (04) : 522 - 522
  • [46] Arterial Spin Labeling Method as a Supplemental Predictor to Distinguish Between High- and Low-Grade Gliomas
    Komatsu, Katsuya
    Wanibuchi, Masahiko
    Mikami, Takeshi
    Akiyama, Yukinori
    Iihoshi, Satoshi
    Miyata, Kei
    Sugino, Toshiya
    Suzuki, Kengo
    Kanno, Aya
    Noshiro, Shouhei
    Ohtaki, Shunya
    Mikuni, Nobuhiro
    WORLD NEUROSURGERY, 2018, 114 : E495 - E500
  • [47] Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas
    Liang, Ruofei
    Chen, Ni
    Li, Mao
    Wang, Xiang
    Mao, Qing
    Liu, Yanhui
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 164 : 50 - 52
  • [48] Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
    Kesari, Santosh
    Schiff, David
    Drappatz, Jan
    LaFrankie, Debra
    Doherty, Lisa
    Macklin, Eric A.
    Muzikansky, Alona
    Santagata, Sandro
    Ligon, Keith L.
    Norden, Andrew D.
    Ciampa, Abigail
    Bradshaw, Joanna
    Levy, Brenda
    Radakovic, Gospova
    Ramakrishna, Naren
    Black, Peter M.
    Wen, Patrick Y.
    CLINICAL CANCER RESEARCH, 2009, 15 (01) : 330 - 337
  • [49] Follow-up study of adults with low-grade gliomas treated with temozolomide
    Kaley, Thomas
    Finlay, Jonathan
    Abrey, Lauren
    Kelly, Patrick
    Pacia, Steven
    Tikoo, Ravinder
    Kuo, Dennis
    Golfinos, John
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 523
  • [50] CARBOPLATIN-BASED CHEMOTHERAPY AFTER TEMOZOLOMIDE FAILURE IN HIGH-GRADE GLIOMAS. VOLUMETRIC ANALYSES
    Nakasu, Satoshi
    Hayashi, Nakamasa
    Mitsuya, Koichi
    Nioka, Hirofumi
    Matsumura, Ken-ichi
    Nakasu, Yoko
    NEURO-ONCOLOGY, 2016, 18 : 7 - 7
12345